Life sciences news
-
argenx announces positive CHMP opinion for subcutaneous efgartigimod for generalized myasthenia gravis
Friday September 15th 2023
Read more
-
New study discovers how neurons die in Alzheimer’s disease
Friday September 15th 2023
Read more
-
Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development
Tuesday September 12th 2023
Read more
-
SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV
Friday September 8th 2023
Read more
-
The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain
Tuesday September 5th 2023
Read more
-
SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure
Friday September 1st 2023
Read more
-
FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEO
Friday September 1st 2023
Read more
-
Belgians send miniature heart into space for ageing research
Wednesday August 30th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus
Tuesday August 29th 2023
Read more
-
AI assists in arthritis diagnosis based on MRI images
Monday August 28th 2023
Read more
-
ViroVet achieves groundbreaking results with antiviral drug against BVD
Monday August 28th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
